Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3058085> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- Q3058085 subject Q10101376.
- Q3058085 subject Q8236084.
- Q3058085 subject Q8412954.
- Q3058085 subject Q8503308.
- Q3058085 subject Q8732560.
- Q3058085 subject Q8844608.
- Q3058085 abstract "Esmirtazapine (ORG-50,081) is a drug which was under development by Organon for the treatment of insomnia and vasomotor symptoms (e.g., hot flashes) associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology, including inverse agonist actions at H1 and 5-HT2 receptors and antagonist actions at α2-adrenergic receptors. As of March 2010, Merck terminated internal clinical development program for esmirtazapine, for hot flashes and insomnia, for strategic reasons.".
- Q3058085 atcPrefix "none".
- Q3058085 casNumber "61337-87-9".
- Q3058085 drugbank "DB00316".
- Q3058085 fdaUniiCode "4685R51V7M".
- Q3058085 iupacName "(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine".
- Q3058085 pubchem "3085218".
- Q3058085 thumbnail Esmirtazapine_2D_structure.svg?width=300.
- Q3058085 wikiPageWikiLink Q10101376.
- Q3058085 wikiPageWikiLink Q128406.
- Q3058085 wikiPageWikiLink Q14864427.
- Q3058085 wikiPageWikiLink Q14877161.
- Q3058085 wikiPageWikiLink Q14982.
- Q3058085 wikiPageWikiLink Q1671731.
- Q3058085 wikiPageWikiLink Q169872.
- Q3058085 wikiPageWikiLink Q172275.
- Q3058085 wikiPageWikiLink Q177708.
- Q3058085 wikiPageWikiLink Q1858291.
- Q3058085 wikiPageWikiLink Q1869874.
- Q3058085 wikiPageWikiLink Q288084.
- Q3058085 wikiPageWikiLink Q3430227.
- Q3058085 wikiPageWikiLink Q410943.
- Q3058085 wikiPageWikiLink Q421930.
- Q3058085 wikiPageWikiLink Q494483.
- Q3058085 wikiPageWikiLink Q753586.
- Q3058085 wikiPageWikiLink Q8236084.
- Q3058085 wikiPageWikiLink Q8386.
- Q3058085 wikiPageWikiLink Q8412954.
- Q3058085 wikiPageWikiLink Q8503308.
- Q3058085 wikiPageWikiLink Q8732560.
- Q3058085 wikiPageWikiLink Q8844608.
- Q3058085 wikiPageWikiLink Q903372.
- Q3058085 wikiPageWikiLink Q9635.
- Q3058085 atcPrefix "none".
- Q3058085 casNumber "61337".
- Q3058085 drugbank "DB00316".
- Q3058085 iupacName "-12341014".
- Q3058085 pubchem "3085218".
- Q3058085 unii "4685".
- Q3058085 type ChemicalSubstance.
- Q3058085 type Drug.
- Q3058085 type ChemicalObject.
- Q3058085 type Thing.
- Q3058085 type Q8386.
- Q3058085 comment "Esmirtazapine (ORG-50,081) is a drug which was under development by Organon for the treatment of insomnia and vasomotor symptoms (e.g., hot flashes) associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacology, including inverse agonist actions at H1 and 5-HT2 receptors and antagonist actions at α2-adrenergic receptors.".
- Q3058085 label "Esmirtazapine".
- Q3058085 depiction Esmirtazapine_2D_structure.svg.